CClinicalTrials.gg
Status unknownNCT04352010TOP+Updated Jul 6, 2022

Therapy Online Plus (TOP+) - Comparing Two Online Interventions for Dealing With Challenging Life Circumstances

An interventional study of Res-Up! and REMOTION in Mental Disorders and Online-Intervention, sponsored by Ulrike Willutzki. Status unknown at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-07-06.

Sponsored by Ulrike Willutzki · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jul 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Psychotherapy interventions can roughly be grouped into compensation-oriented strategies (compensating for and and modifying personal deficits of patients) versus capitalization-oriented strategies (building on patients' personal strengths). Improvement of emotion regulation (compensation-oriented) as well as the activation of resilience (capitalisation-oriented) have been identified as important transdiagnostic factors in the treatment of mental disorders. The study aims to compare compensation vs. capitalization strategies by using two online programs, centered either on emotion-regulation ("REMOTION") or on activating resilience ("Res-Up!"). Res-Up! and REMOTION are administered as stand-alone intervention or as add-on treatment to standard psychotherapy.

Participants will be randomly assigned to three study conditions (Res-Up!, REMOTION, waiting control group). Outcomes are assessed at baseline, after six weeks and after twelve weeks.

02

Conditions studied

  • Mental Disorders
  • Online-Intervention

Browse trials for

Keywords

  • Internet-based Therapy
  • Resilience
  • Emotion Regulation
  • Outcome Research
  • Strengths
  • Psychotherapy
03

In context

Mental Disorders

2,107 studies on the registry are indexed under Mental Disorders; 416 are open to participants now.

This study's planned enrollment of 200 is above the median of 94 across 1,574 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Ulrike Willutzki is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of a mental disorder according to DSM-5
  • Recruited at the training centers of the German Association for Behavior Therapy (Deutsche Gesellschaft für Verhaltenstherapie, DGVT) at Muenster, Bielefeld and Dortmund or at the Center of Mental Health and Psychotherapy, Witten/Herdecke University (all outpatients clinics

Exclusion criteria

Exclusion Criteria:

  • Insufficient German language skills
  • Current severe episode of major depression
  • Psychotic disorder
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Online-Intervention "Res-Up!"

    Participants in the Res-Up! group get access to Res-Up! while waiting for psychotherapy or in addition to psychotherapy. Participants will answer questionnaires after inclusion as well as six and twelve weeks later.

    Behavioral: Res-Up!

  • Experimental
    Online-Intervention "REMOTION"

    Participants in the REMOTION group get access to REMOTION while waiting for psychotherapy or in addition to psychotherapy. Participants will answer questionnaires after inclusion as well as six and twelve weeks later.

    Behavioral: REMOTION

  • Experimental
    Wait-control group

    Participants in the wait-control group will not get access to the online-tools while waiting for psychotherapy or while in psychotherapy. Participants will answer questionnaires after inclusion, six weeks later and twelve weeks later.They get access to one of the online-tools after 12 weeks.

    Other: Wait-Control Group

Interventions

  • BehavioralRes-Up!

    Res-Up! is an internet-based intervention focusing on patients' strengths and positive experiences that have effects on distress, protective factors and quality of life. The intervention is based on the Personal Model of Resilience (PMR; Padesky and Mooney, 2012), which is a positive intervention that utilizes patients' strengths to overcome problems.The PMR activates resilient emotions, thoughts, metaphors, images and behaviors in four steps during five sessions about the aquisition of resilient strategies and their use in daily life. A variety of elements based on different psychotherapy approaches (Cognitive Behavioral Therapy, Emotion Focused Therapy, Positive Therapy etc.) are integrated in the program. Participants should work through one module per week. The intervention is conducted as I-CBT via the platform Minddistrict.Res-Up! is administered as a standalone or an add-on treatment to psychotherapy.

  • BehavioralREMOTION

    REMOTION is an internet-based intervention aimed at transdiagnostically reducing symptom severity and improving emotion regulation of psychotherapy patients. The structure of REMOTION is based on the idea of an extended process model of emotion regulation as postulated by J.J. Gross (2015). The program includes the following modules: introduction, psychoeducation, identification, selection, implementation and modification. A variety of elements based on different psychotherapy approaches (Cognitive Behavioral Therapy, Emotion Focused Therapy, Dialectical Behavior Therapy etc.) are integrated in the program. Participants should work through one module per week. REMOTION is administered as a standalone or an add-on treatment to psychotherapy.

  • OtherWait-Control Group

    In the waiting control group participants will answer questionnaires and they will gain access to either REMOTION or Res-Up! after twelve weeks.

06

What researchers measure

Primary outcomes

  1. Change on Brief Symptom Inventory - short form (BSI-18) over multiple time points

    Franke, 2000; Internationally used self-report of symptom severity of patients \[18 items\] that includes three symptom scales, each including six items: Somatization, Depression, and Anxiety. Each measured on a 5-point scale according to how much one has been bothered by the symptom in the prior week.

    Time frame: Change from Baseline, then after six weeks and after twelve weeks

Secondary outcomes

  1. Change on Patient Health Questionnaire-9 (PHQ-9) over multiple time points

    Kroenke, Spitzer, \& Williams, 2001; Internationally used self-report for screening, diagnosing, monitoring and measuring the severity of depression \[9 items, 4-point scale ("not at all" to "nearly every day")\]. It is the major depressive disorder module of the full PHQ.

    Time frame: Baseline, then after six weeks and after twelve weeks

  2. Change on Witten Resource Questionnaire (WIRF) over multiple time points

    Schürmann et al., 2019; Self-report of personal and external resources \[37 items, 6-point Likert scale ("strongly disagree" to "strongly agree")\]. Resources are measured in the three contexts: "everyday life", "crises well coped with" and "current problems" each including three subscales (action regulation, relaxation and social support).

    Time frame: Change from Baseline, then after six weeks and after twelve weeks

  3. Change on Rosenberg-Self-Esteem Scale (RSES) over multiple time points

    Ferring \& Filipp, 1996; Self-report of general self-esteem \[10 items, 4-point scale ("strongly disagree" to "strongly agree")\]. A total score will be computed with summed item scores (range: 0-30).

    Time frame: Change from Baseline, then after six weeks and after twelve weeks

  4. Change on Connor-Davidson Resilience Scale (CD-RISC-10) over multiple time points

    Sarubin et al., 2015; Internationally used self-report of individual resilience \[short version: 10 items, each rated on a 5-point scale (0-4), with higher scores reflecting stronger resilience\]. A total score will be computed with averaged item scores.

    Time frame: Change from Baseline, then after six weeks and after twelve weeks

  5. Change on Self-assessment of Emotion Regulation Skills (Selbsteinschätzung emotionaler Kompetenzen; SEK-27) over multiple time points

    Berking \& Znoj, 2008; Self-Report Measure for the Assessment of Emotion Regulation Skills \[27 items, 9 subscales, 5-point Likert scale ("not at all" to "always")\].

    Time frame: Change from Baseline, then after six weeks and after twelve weeks

  6. Change on Self-Compassion Scale (SCS-D) over multiple time points

    Neff, 2003; Internationally used self-report of of self-compassion \[26 items, 6 subscales, 5-point scale ("almost never" to "almost always")\]. Participants will be asked to rate the items according to how often they behave in the stated manner towards themselves in difficult times.

    Time frame: Change from Baseline, then after six weeks and after twelve weeks

  7. Change on Working Alliance Inventory (WAI) between two time points

    Wilmers et al., 2008; Internationally used self-report of therapeutic alliance measuring bond, goals and tasks in psychotherapy based on feedback of patients concerning the current therapy session \[online version: 12 items, 5-point Likert scale ("rarely or never" to "always")\].

    Time frame: Change from six weeks after treatment to twelve weeks after

  8. Change on Questionnaire Assessing the Acceptance of Unpleasant and Pleasant Emotions (Fragebogen zur Akzeptanz von Gefühlen; FrAGe) over multiple time points

    Beblo et al., 2011; Self-report of the acceptance and supression of unpleasant and unpleasant emotions \[32 items, 2 subscales: Pleasant and Unpleasant emotions, 6-point scale ("strongly disagree" to "strongly agree")\].

    Time frame: Change from Baseline, then after six weeks and after twelve weeks

  9. Change on Positive and Negative Affect Schedule (PANAS) over multiple time points

    Watson, Clark, \& Tellegen, 1988; Internationally used self-report of positive and negative affect \[10 items, 5-point scale ("very slightly or not at all" to "extremely")\]. Participants will be asked to rate the items according to how they feel "in the current moment". The PANAS includes two subscales of global positive affect (ten items, range: 1-5) and global negative affect (10 items, range: 1-5). Only the subscale of global positive affect will be used. Subscale scores are computed with averaged item scores.

    Time frame: At the beginning of every subpart of the intervention, every week up to 5 weeks

07

Study locations

1 of 1 sites recruiting
  • Witten/Herdecke University
    Witten, North Rhine-Westphalia 58455, Germany
    • Leonie F Trimpop, M.Sc. · Contact
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04352010
Lead sponsor
Ulrike Willutzki
Collaborators
University of Bern
Responsible party
Ulrike Willutzki (Professor, Clinical Psychology and Psychotherapy, University of Witten/Herdecke) — Sponsor-investigator
First posted
Apr 17, 2020
Start date
Apr 13, 2020
Primary completion
Jul 2022 (estimated)
Completion
Apr 2023 (estimated)
Last update
Jul 6, 2022

Study contacts

Leonie F Trimpop, M.Sc.
Contact
leonie.trimpop@uni-wh.de
+(0)49 2302 926 9704
Ulrike Willutzki, Prof. Dr.
study chair · Witten/Herdecke University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion